Transcription of DATA SHEET 1 CLEXANE AND CLEXANE FORTE 2 …
{{id}} {{{paragraph}}}
Example: quiz answers
DATA SHEET 1 CLEXANE AND CLEXANE FORTE 2 …
New Zealand Data SHEET CLEXANE - CLEXANE - FORTE -ccdsv14-dsv21-27ju l21 Page 1 DATA SHEET 1 CLEXANE AND CLEXANE FORTE * 2 QUALITATIVE AND QUANTITATIVE COMPOSITION CLEXANE SYRINGES # Pre-filled syringes, ready-to-use: 20 mg injection enoxaparin sodium 20mg (equivalent to 2,000 IU anti-Xa activity) in mL 40 mg injection enoxaparin sodium 40mg (equivalent to 4,000 IU anti-Xa activity) in mL Pre-filled graduated syringes with graduated markings, ready-to-use: 60 mg injection enoxaparin sodium 60mg (equivalent to 6,000 IU anti-Xa activity) in mL 80 mg injection enoxaparin sodium 80mg (equivalent to 8,000 IU anti-Xa activity) in mL 100 mg injection enoxaparin sodium 100mg (equivalent to 10,000 IU anti-Xa activity) in mL CLEXANE (with safety lock system) Pre-filled syringes, ready-to-use: 20 mg injection enoxaparin sodium 20mg (equivalent to 2,000 IU anti-Xa activity) in mL 40 mg injection enoxaparin sodium 40mg (equivalent to 4,000 IU anti-Xa activity) in mL Pre-filled graduated syringes with graduated markings, ready-to-use: 60 mg injection enoxaparin sodium 60mg (equivalent to 6,000 IU anti-Xa activity) in mL 80 mg injection enoxaparin sodium 80mg (equivalent to 8,000 IU)
illnesses including acute heart failure, respiratory failure, severe infections, rheumatic disease. ... anaesthesia is to be performed (see section 4.4 – Spinal/Epidural Anaesthesia). Prophylaxis should be continued at 40 mg once daily for 7 to 10 days or until the risk of
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: